InMed Pharmaceuticals Inc. (INM) Stock Overview
Explore InMed Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
InMed Pharmaceuticals Inc. (INM)
Key Financials
Key Financials
Market Cap
2.4M
P/E Ratio
-0.00
EPS (TTM)
$-5.44
ROE
-0.73%
INM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of InMed Pharmaceuticals Inc. (NASDAQ: INM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, InMed Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INM on the NASDAQ shows an RSI of 38.77, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind InMed Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 2.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of INM on the NASDAQ.